EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 9 March 2023

Blogs

International Women's Day 2023
08 March 2023

Collectively we can all #EmbraceEquity Read more

From COVID-19 Pandemic to War: Clinical Trial Industry Powers On Under Extreme Conditions (Guest...
08 March 2023

Special Section: Clinical Research in Ukraine Read more

Because we can't afford not to: Let’s make a joint health check for CVD and diabetes happen

Between 28 February and 2 March policymakers, experts, researchers, patients and industry representatives gathered in the European Parliament to discuss the importance of early diagnosis to reduce preventable and premature mortality and explore key policy recommendations to make joint cardiovascular and diabetes health checks a reality.

Istvan Ujhelyi - MEP
... Read more

Valerie Humphreys - Diabetes Advocate
... Read more

Events

Women’s Brain Project special webinar
13 March 2023 (Online)

Sex, gender and the brain: Towards an inclusive research agenda Read more

GetReal Institute Annual Conference 2023
16 March 2023 (Utrecht, Netherlands)

A European Outlook on Real World Evidence in a Global Context Read more

DIA Europe 2023 - 35th Anniversary of the event
22 March 2023 (Basel, Switzerland)

35th Anniversary of the event Read more

Healthier Hearts
22 March 2023 (Stockholm + digital)

Why boosting cardiovascular health policy is critical for Europe Read more

What we are reading

Vouchernomics: Meet pharma’s most controversial incentive
On 06 March 2023 (POLITICO)

Opinion is split on whether transferable exclusivity vouchers are the right solution to antimicrobial resistance. Read more

Europe will lose out on medical innovation if draft EU reforms pass - Novo Nordisk CEO
On 03 March 2023 (Reuters)

Novo Nordisk CEO Lars Fruergaard Jorgensen stresses how Europe will lose out to countries like the US and Japan on new... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu